All News

In some cases, choosing the mundane can be life-giving, help salve emotional hurts and anchor our lives.

Recent study findings show no significant difference in treatment efficacy or overall survival between men and women.

Faith can be a tricky thing when you are dealing with cancer.

In a talk to people affected by melanoma, Michael McGrady described reassessing his values after cancer and how it changed the course of his life.

There is value in information being shared from survivor to survivor. Many health issues may be common, but you can feel alone if you are not aware of them. A well-moderated online support group may be a great place to gain knowledge and comfort.

Compared with single-agent therapy, the combination of Yervoy and Opdivo showed a 38% overall response rate.

We've got a sneak peek at what’s inside CURE®'s spring issue.

The Food and Drug Administration granted a fast track designation to momelotinib for the treatment of patients with intermediate/high-risk myelofibrosis who have previously received a JAK inhibitor.

Isn’t everyone a survivor from the time of diagnosis to the end? One reader thinks so.

A breast cancer survivor who had a double mastectomy with reconstruction talks about her nipple coloring process.

In a talk about her new book, Vanessa Bayer explains how leukemia contributed to her comic perspective and sense of empathy.

Having hope in the now is really faith in the future.

Here are the top 5 CURE stories for May 2019.

My tips and experience as a new acupuncture patient follow as a potential guide to getting beyond any fear of the procedure and potentially understanding the benefits of multiple sessions.

A male breast cancer survivor shares a note of gratitude to his surgeon.

Recently, I had my first experience with CBD oil and wrote a post about it on my blog. That was almost two months ago. Since that time, I’ve learned a lot more about using cannabidiol and the benefits associated with use. In this post, I’ll expound on the things I’ve learned through firsthand experience.

From today’s top performers to the latest in scientific research, here’s what is making headlines in the cancer space this week.

The Food and Drug Administration granted a priority review to Darzalex in combination with Velcade (bortezomib), thalidomide and dexamethasone, also known as Vtd, for the front-line treatment of newly diagnosed patients with multiple myeloma.

Patients with chronic lymphocytic leukemia have newer options that include targeted therapy combinations and CAR-T cell therapy.

The Aplastic Anemia and MDS International Foundation records educational webinars for patients.

On June 19, the webinar to be presented is “Shared Decision Making - Empowering Patients,” taught by Susan Berg, MS, LGC, from the Center for Shared Decision Making at Dartmouth – Hitchcock.

Cancer can both open and close doors. It can make life feel crowded and foreign. It can bring out both the best and the worst in people, much like being on a crowded elevator can. As it creates space in our life it can also push us out of our comfort zones but it doesn't change who we are.

After I lost my real breasts, I gave up hope of ever having a "nice" body again.

Remembering to remain present through cancer.

In an interview with PEOPLE, "Jeopardy!" Host Alex Trebek reported he is in “near remission” from his stage 4 pancreatic cancer diagnosis.

Following surgery with medication, combining immunotherapies or targeted drugs and adding radiation to immunotherapy can improve effectiveness in treating various stages of melanoma.

Is this relative of the coffee plant a safer alternative to opioids or a dangerous, unregulated drug?

The Food and Drug Administration has approved the combination regimen of Revlimid plus Rituxan for use in patients with previously-treated follicular lymphoma and marginal zone lymphoma.